Recital 14, Regulation (EU) 2022/2346

In force

Transitional provisions should be laid down also for products covered by Annex XVI to Regulation (EU) 2017/745 for which notified bodies have issued certificates in accordance with Council Directive 93/42/EEC [Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p. 1).]. Also for those products, it is not possible for the manufacturer to complete clinical investigations and the conformity assessment within 6 months.